Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations

Pathology Oncology Research : POR
Tamás GarayBalázs Hegedűs

Abstract

BRAF and NRAS are the two most frequent oncogenic driver mutations in melanoma and are pivotal components of both the EGF and FGF signaling network. Accordingly, we investigated the effect of BRAF and NRAS oncogenic mutation on the response to the stimulation and inhibition of epidermal and fibroblast growth factor receptors in melanoma cells. In the three BRAF mutant, two NRAS mutant and two double wild-type cell lines growth factor receptor expression had been verified by qRT-PCR. Cell proliferation and migration were determined by the analysis of 3-days-long time-lapse videomicroscopic recordings. Of note, a more profound response was found in motility as compared to proliferation and double wild-type cells displayed a higher sensitivity to EGF and FGF2 treatment when compared to mutant cells. Both baseline and induced activation of the growth factor signaling was assessed by immunoblot analysis of the phosphorylation of the downstream effectors Erk1/2. Low baseline and higher inducibility of the signaling pathway was characteristic in double wild-type cells. In contrast, oncogenic BRAF or NRAS mutation did not influence the response to EGF or FGF receptor inhibitors in vitro. Our findings demonstrate that the oncogenic muta...Continue Reading

References

Jul 1, 1994·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·H Maruta, A W Burgess
Dec 1, 1994·International Journal of Cancer. Journal International Du Cancer·W BergerM Micksche
Nov 1, 1993·The Journal of Investigative Dermatology·D J EastyD C Bennett
Jun 21, 1996·The Journal of Biological Chemistry·D M OrnitzM Goldfarb
Oct 9, 2001·Experimental Dermatology·C Gordon-ThomsonG P Moore
Mar 8, 2002·Pathology Oncology Research : POR·A LadányiI Kovalszky
Mar 12, 2002·The Journal of Investigative Dermatology·A DemunterJ J van den Oord
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Mar 22, 2003·Experimental Cell Research·Raymond C HarrisRobert J Coffey
Aug 23, 2003·Current Biology : CB·Neil O CarragherMargaret C Frame
Dec 18, 2003·Journal of the National Cancer Institute·Janet L MaldonadoBoris C Bastian
Mar 11, 2004·The Journal of Investigative Dermatology·Hensin TsaoFrank G Haluska
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eunice L KwakDaniel A Haber
Jun 23, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Friedegund MeierMeenhard Herlyn
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Apr 7, 2006·The Journal of Biological Chemistry·Xiuqin ZhangDavid M Ornitz
Mar 21, 2007·Cancer Letters·Pinaki R Dutta, Amit Maity
Jun 28, 2007·International Journal of Cancer. Journal International Du Cancer·Zsuzsa RákosyMargit Balázs
Mar 8, 2008·The Journal of Investigative Dermatology·Roland HoubenJuergen C Becker
Dec 17, 2008·The Journal of Investigative Dermatology·Tobias SinnbergFriedegund Meier
Dec 27, 2008·The International Journal of Biochemistry & Cell Biology·Georgia ChalkiadakiGeorge N Tzanakakis
Jan 17, 2009·Molecular Cancer Research : MCR·Michael G GartsidePamela M Pollock
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nikolaus SchicherChristoph Hoeller
Feb 4, 2010·Expert Review of Dermatology·Papia Ghosh, Lynda Chin
Feb 24, 2010·Clinical & Experimental Metastasis·József TímárErzsébet Rásó
Feb 16, 2011·Pigment Cell & Melanoma Research·David J EastyDorothy C Bennett
Mar 1, 2011·Journal of Cutaneous Pathology·Barbara BooneLieve Brochez
Mar 8, 2011·Expert Opinion on Therapeutic Targets·Christine HeinzleBrigitte Marian
Jul 9, 2011·Melanoma Research·Sapna P PatelAgop Y Bedikian
Jul 15, 2011·The Journal of Investigative Dermatology·Thomas MetznerMichael Grusch
Oct 4, 2011·Trends in Molecular Medicine·Zhenyu JiHensin Tsao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.